Neurogene Inc. (NASDAQ: NGNE)
$45.74
-0.2100 ( -0.46% ) 90.0K
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.
Market Data
Open
$45.74
Previous close
$45.95
Volume
90.0K
Market cap
$593.85M
Day range
$44.25 - $47.31
52 week range
$12.49 - $53.00
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 51 | Jun 21, 2024 |
| 8-k | 8K-related | 15 | Jun 18, 2024 |
| 4 | Insider transactions | 1 | Jun 17, 2024 |
| 4 | Insider transactions | 1 | Jun 17, 2024 |
| 4 | Insider transactions | 1 | Jun 17, 2024 |
| 4 | Insider transactions | 1 | Jun 17, 2024 |
| 8-k | 8K-related | 13 | Jun 17, 2024 |
| 4 | Insider transactions | 1 | Jun 17, 2024 |
| 8-k | 8K-related | 15 | Jun 03, 2024 |
| 10-q | Quarterly Reports | 80 | May 10, 2024 |